Three years follow-up of screen-detected diabetic and non-diabetic subjects: Who is better off? The ADDITION Netherlands study

BMC Family Practice

Volumn 9, Issue , 2008, Pages

  Janssen, Paul G H ^a   Gorter, Kees J ^a   Stolk, Ronald P ^b   Akarsubasi, Mehmet ^a   Rutten, Guy E H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 68149122852     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-9-67     Document Type: Article

References (25)

1. Economic costs of diabetes in the U.S. in 2002. American Diabetes Association, Diabetes Care 2003 26 917 932 10.2337/diacare.26.7.2194 12610059
2. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. N Unwin J Shaw P Zimmet KG Alberti, Diabet Med 2002 19 708 723 10.1046/j.1464-5491.2002.00835.x 12207806
3. Higher medical care costs accompany impaired fasting glucose. GA Nichols JB Brown, Diabetes Care 2005 28 2223 2229 16123494 10.2337/diacare.28.9.2223
4. Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions. G Wylie AP Hungin J Neely, BMJ 2002 324 1190 1192 12016185 10.1136/bmj.324.7347.1190
5. What is the risk of mortality for people who are screen positive in a diabetes screening programme but who do not have diabetes on biochemical testing? Diabetes screening programmes from a public health perspective. AM Spijkerman SJ Griffin JM Dekker G Nijpels NJ Wareham, J Med Screen 2002 9 187 190 10.1136/jms.9.4.187 12518011
6. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. AM Spijkerman MC Adriaanse JM Dekker G Nijpels CDA Stehouwer LM Bouter RJ Heine, Diabetes Care 2002 25 1784 1789 10.2337/diacare.25.10.1784 12351478
7. Screening for type 2 diabetes (Position Statement). American Diabetes Association, Diabetes Care 2004 27 Suppl 1 S11 S14 14693922
8. Screening for type 2 diabetes - should it be now? K Borch-Johnsen T Lauritzen C Glümer A Sandbaek, Diabet Med 2003 20 175 181 10.1046/j.1464-5491.2003.00842.x 12675659
9. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. T Lauritzen S Griffin K Borch-Johnsen NJ Wareham BHR Wolffenbuttel GEH Rutten, Int J Obes Relat Metab Disord 2000 24 Suppl 3 S6 S11 11063279
10. Dutch College of General Practitioners' guidelines on type 2 diabetes mellitus [in Dutch]. GEHM Rutten S Verhoeven RJ Heine WJC De Grauw PVM Cromme K Reenders E Van Ballegooie T Wiersma, Huisarts Wet 1999 42 67 84
11. Low yield of population-based screening for Type 2 diabetes in the Netherlands: the ADDITION Netherlands study. PGH Janssen KJ Gorter RP Stolk GEHM Rutten, Fam Pract 2007 24 555 561 10.1093/fampra/cmm052 17962235
12. Progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screening programme in general practice: the ADDITION Study, Denmark. SS Rasmussen C Glümer A Sandbaek T Lauritzen K Borch-Johnsen, Diabetologia 2007 50 293 297 10.1007/s00125-006-0530-y 17143605
13. Performance of an NIDDM screening questionnaire based on symptoms and risk factors. JB Ruige JND de Neeling PJ Kostense LM Bouter RJ Heine, Diabetes Care 1997 20 491 496 10.2337/diacare.20.4.491 9096967
14. Definition, diagnosis and classification of diabetes mellitus and its Complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. KG Alberti PZ Zimmet, Diabet Med 1998 15 539 553 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 9686693
15. Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose. JJ Wang SY Yuan LX Zhu HJ Fu HB Li G Hu J Tuomilehto, Diabetes Res Clin Pract 2004 66 183 191 10.1016/j.diabres.2004.03.002 15533586
16. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. F De Vegt JM Dekker A Jager E Hienkens PJ Kostense CD Stehouwer G Nijpels LM Bouter RJ Heine, JAMA 2001 285 2109 2113 10.1001/jama.285.16.2109 11311100
17. Reproducibility of the diagnosis of diabetes over a 30-month follow-up: the Paris Prospective Study. E Eschwege MA Charles D Simon N Thibult B Balkau Paris Prospective Study, Diabetes Care 2001 24 1941 1944 10.2337/diacare.24.11. 1941 11679461
18. Risk of diabetes in the new diagnostic category of impaired fasting glucose: a prospective analysis. O Vaccaro G Ruffa G Imperatore V Iovino AA Rivellese G Riccardi, Diabetes Care 1999 22 1490 1493 10.2337/diacare.22.9.1490 10480514
19. Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study. NL Smith JI Barzilay D Shaffer PJ Savage SR Heckbert LH Kuller RA Kronmal HE Resnick BM Psaty, Arch Intern Med 2002 162 209 216 10.1001/archinte.162.2.209 11802755
20. Post-challenge hyperglycaemia is associated with premature death and macrovascular complications. Q Qiao J Tuomilehto K Borch-Johnsen, Diabetologia 2003 46 Suppl 1 M17 M21 12652354
21. Impaired fasting glucose is not a risk factor for atherosclerosis. M Hanefeld T Temelkova-Kurktschiev F Schaper E Henkel G Siegert C Koehler, Diabet Med 1999 16 212 218 10.1046/j.1464-5491.1999.00072.x 10227566
22. Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging. DR Blake JB Meigs DC Muller SS Najjar R Andres DM Nathan, Diabetes 2004 53 2095 2100 10.2337/diabetes.53.8.2095 15277391
23. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. J Tuomilehto J Lindström JG Eriksson TT Valle H Hämäläinen P Ilanne-Parikka S Keinänen-Kiukaanniemi M Laakso A Louheranta M Rastas V Salminen M Uusitupa Finnish Diabetes Prevention Study Group, N Engl J Med 2001 344 1343 1350 10.1056/NEJM200105033441801 11333990
24. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. WC Knowler E Barrett-Connor SE Fowler RF Hamman JM Lachin EA Walker DM Nathan Diabetes Prevention Program Research Group, N Engl J Med 2002 346 393 403 11832527 10.1056/NEJMoa012512
25. The prevention of type 2 diabetes: general practitioner and practice nurse opinions. R Williams F Rapport G Elwyn B Lloyd J Rance S Belcher, Br J Gen Pract 2004 54 531 535 15239916